ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jaffre, S.
Right arrow Articles by Thiberville, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jaffre, S.
Right arrow Articles by Thiberville, L.
Eur Respir J 2006; 27:644-646
Copyright ©ERS Journals Ltd 2006

Fatal haemoptysis in a case of lymphomatoid granulomatosis treated with rituximab

S. Jaffre1, F. Jardin2, S. Dominique1, E. Duet1, Ph. Hubscher3, A. Genevois4, F. Corne1, S. Bota1, G. Nouvet1 and L. Thiberville1

1 Clinique pneumologique and, 4 Service de radiologie, CHU Rouen, and 2 Service hématologie, Centre Bequerel, Rouen, and 3 Service de pneumologie, Hopital Jacques Monod, Le Havre, France.

CORRESPONDENCE: S. Jaffré, Service de Pneumologie, Hôpital Guillaume et René Laennec, Boulevard Jacques Monod, 44093 Nantes Cedex 1, France. Fax: 33 240165241. E-mail: sandrine.jaffre{at}chu-nantes.fr

Keywords: Haemoptysis, lymphomatoid granulomatosis, rituximab

Received: July 21, 2004
Accepted August 15, 2005

Lymphomatoid granulomatosis is a rare angiocentric and angiodestructive disease, which commonly involves the lungs but also the brain, kidneys, liver and skin. This report describes the case of a 33-yr-old female with an aggressive form of lymphoid granulomatosis treated with an anti-CD20 antibody. Dramatic radiological improvement was seen at the fourth week. However, the patient died at home 1 month after the last rituximab administration from a massive haemoptysis.




This article has been cited by other articles:


Home page
 NEJMHome page
E. P. Hochberg, M. D. Gilman, and R. P. Hasserjian
Case records of the Massachusetts General Hospital. Case 17-2006--a 34-year-old man with cavitary lung lesions.
N. Engl. J. Med., June 8, 2006; 354(23): 2485 - 2493.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the European Respiratory Society.